Condition
PHACE Syndrome
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Active Not Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03440697Active Not Recruiting
Pathogenetic Basis of Aortopathy and Aortic Valve Disease
NCT05133245Enrolling By InvitationPrimary
PHACE - Prospective Genetic Investigation
NCT01016756CompletedPrimary
Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)
NCT01018082CompletedPrimary
Longitudinal Study of Neurologic, Cognitive, and Radiologic Outcomes of PHACE Syndrome
Showing all 4 trials